GS
Gregg W. Stone
Highly rated in
31
conditions

Dr. Gregg W. Stone

New York Office
New York, NY
Highly rated in
31
conditions
Specialties:Cardiology | Interventional Cardiology
Experience:41 Years
Clinical Trials:Currently Recruiting for 2 Trials
Highly rated in
31
conditions
About|Expertise|Insurance|Location|Research
Areas of Expertise

Many doctors have expertise treating multiple conditions. MediFind uses a variety of data sources to determine what conditions a doctor treats and their level of experience.

Check Dr. Gregg W. Stone's experience treating your condition:
About Dr. Gregg W. Stone

Gregg Stone is a Cardiologist and an Interventional Cardiologist in New York, New York. Stone has been practicing medicine for over 41 years and is highly rated in 31 conditions, according to our data. His top areas of expertise are Heart Attack, Coronary Heart Disease, Acute Coronary Syndrome, Percutaneous Coronary Intervention (PCI), and Angioplasty. He is licensed to treat patients in New York.

His clinical research consists of co-authoring 1208 peer reviewed articles and participating in 27 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Gregg W. Stone it is best to call his office and ask if your insurance is accepted.

Call to see if your plan is accepted.
Locations
161 Fort Washington Ave, New York, NY 10032
Background & Education
Graduate Institution
Johns Hopkins University School Of Medicine, 1982
Specialties
Cardiology
Interventional Cardiology
Licenses
Internal Medicine in NY
Languages Spoken
English
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

25 Clinical Trials
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II
Enrollment Status: Recruiting
Publish Date: December 08, 2022
Intervention Type: Device, Other
Study Phase: Not Applicable
Clinical Study of the BioVentrix Revivent TC™ System for Treatment of Left Ventricular Aneurysms (ALIVE)
Enrollment Status: Recruiting
Publish Date: March 11, 2021
Intervention Type: Device
Study Phase: Phase 2/Phase 3
The Preventive Coronary Intervention on Stenosis With Functionally Insignificant Stenosis With Vulnerable Plaque Characteristics
Enrollment Status: Active, not recruiting
Publish Date: December 13, 2022
Intervention Type: Device, Drug
Study Drug: Optimal Medical treatment
Study Phase: Phase 4
RELIEVE-HF TRIAL: REducing Lung congestIon Symptoms Using the v-wavE Shunt in adVancEd Heart Failure
Enrollment Status: Active, not recruiting
Publish Date: October 28, 2022
Intervention Type: Other, Device
Study Phase: Not Applicable
A Clinical Evaluation of the Safety and Effectiveness of the MitraClip® System for the Treatment of Functional Mitral Regurgitation in Symptomatic Heart Failure Subjects (COAPT Recruitment Closed). COAPT CAS (Recruitment Closed)
Enrollment Status: Active, not recruiting
Publish Date: September 28, 2022
Intervention Type: Device
Study Phase: Not Applicable
A Randomized Controlled Study to Evaluate the Safety and Efficacy of Pressure-controlled Intermittent Coronary Sinus Occlusion (PiCSO) in Anterior STEMI Patients With TIMI 0-2 at Presentation.
Enrollment Status: Not yet recruiting
Publish Date: August 22, 2022
Intervention Type: Device
Study Phase: Not Applicable
Randomized Trial Of Hybrid Coronary Revascularization Versus Percutaneous Coronary Intervention
Enrollment Status: Completed
Publish Date: May 26, 2022
Intervention Type: Device, Procedure
Study Phase: Not Applicable
Coronary Orbital Atherectomy System Study
Enrollment Status: Completed
Publish Date: December 14, 2021
Intervention Type: Device
Study Phase: Not Applicable
Evaluation of XIENCE Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization.
Enrollment Status: Completed
Publish Date: April 07, 2020
Intervention Type: Device, Procedure
Study Phase: Not Applicable
Dual Arm Factorial Randomized Trial in Patients w/ST Segment Elevation AMI to Compare the Results of Using Anticoagulation With Either Unfractionated Heparin + Routine GP IIb/IIIa Inhibition or Bivalirudin + Bail-out GP IIb/IIIa Inhibition; and Primary Angioplasty With Stent Implantation With Either a Slow Rate-release Paclitaxel-eluting Stent (TAXUS™) or Uncoated Bare Metal Stent (EXPRESS2™)
Enrollment Status: Completed
Publish Date: December 04, 2017
Intervention Type: Drug, Device
Study Phase: Phase 3
A Multi-Center Evaluation of the Delivery of Intracoronary Hyperoxemic Supersaturated Oxygen Therapy for 60 Minutes in Anterior Acute Myocardial Infarction Patients With Successful Reperfusion (Via PCI) ≤ Six Hours After Symptom Onset
Enrollment Status: Unknown status
Publish Date: September 26, 2017
Intervention Type: Device
Study Phase: Not Applicable
A Randomized Pilot Trial of the Use of a Distal Protection Device to Prevent Peri-procedural MI During Dilation of Coronary Stenoses Caused by Plaques With Large Lipid Cores
Enrollment Status: Terminated
Publish Date: June 12, 2017
Intervention Type: Device
Study Phase: Not Applicable
Post-Myocardial Infarction Remodeling Prevention Therapy
Enrollment Status: Completed
Publish Date: December 15, 2016
Intervention Type: Device
Study Phase: Phase 2
PRESERV (Prospective Randomized Evaluation to Study the Effects of Reduced Contrast Media on the Vitality of the Kidney) Pivotal Trial
Enrollment Status: Terminated
Publish Date: December 12, 2016
Intervention Type: Other, Device
Study Phase: Not Applicable
A Prospective, Global, Multicenter, Non-Randomized, Non-Blinded Study in Patients With Intermediate Coronary Lesions to Examine the Correlation Between Fractional Flow Reserve (FFR) and Intravascular Ultrasound With Virtual Histology (VH-IVUS)
Enrollment Status: Completed
Publish Date: December 10, 2015
Intervention Type: Device
VELOCITY: Pilot Study to Evaluate Ultrafast Hypothermia Before Reperfusion in Patients With Acute ST-Elevation Myocardial Infarction
Enrollment Status: Terminated
Publish Date: July 25, 2014
Intervention Type: Other, Device
Study Phase: Phase 2
Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents
Enrollment Status: Completed
Publish Date: January 23, 2013
Intervention Type: Device
EXCEL Clinical Trial (Universal Registry)
Enrollment Status: Completed
Publish Date: December 04, 2012
SPIRIT IV Clinical Trial: Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Enrollment Status: Completed
Publish Date: November 07, 2012
Intervention Type: Device
Study Phase: Phase 3
SPIRIT III: A Clinical Evaluation of the Investigational Device XIENCE V® Everolimus Eluting Coronary Stent System (EECSS) in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Enrollment Status: Completed
Publish Date: November 23, 2011
Intervention Type: Device
Study Phase: Phase 3
A Prospective, Randomized Trial Evaluating Slow-Release Formulation TAXUS Paclitaxel-Eluting Coronary Stent in the Treatment of In-Stent Restenosis
Enrollment Status: Completed
Publish Date: August 06, 2010
Intervention Type: Device, Procedure
Study Phase: Phase 2/Phase 3
TAXUS V: De Novo Lesion: A Randomized, Double-blind Trial to Assess TAXUS Paclitaxel-Eluting Coronary Stents, SR Formulation, in the Treatment of De Novo Coronary Lesions
Enrollment Status: Completed
Publish Date: August 06, 2010
Intervention Type: Device
Study Phase: Phase 2/Phase 3
Providing Regional Observations to Study Predictors of Events in the Coronary Tree (PROSPECT) An Imaging Study in Patients With Unstable Atherosclerotic Lesions
Enrollment Status: Completed
Publish Date: May 25, 2010
TAXUS IV-SR: Treatment of De Novo Coronary Disease Using a Single Paclitaxel-Eluting Stent
Enrollment Status: Completed
Publish Date: October 08, 2008
Intervention Type: Device
Study Phase: Phase 2/Phase 3
COOL RCN: Cooling to Prevent Radiocontrast Nephropathy in Patients Undergoing Diagnostic or Interventional Catheterization
Enrollment Status: Terminated
Publish Date: August 05, 2008
Intervention Type: Device
Study Phase: Phase 2/Phase 3
View 23 Less Clinical Trials -
1207 Total Publications
Survival After Invasive or Conservative Management of Stable Coronary Disease.
Journal: Circulation
Published: November 06, 2022
Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors
SK
Dr. Susheel K. Kodali
Interventional Cardiology | Cardiology
Highly rated in
33
conditions
Interventional Cardiology
Cardiology

NewYork-Presbyterian Healthcare System

NewYork-Presbyterian/Columbia University Irving Medical Center

161 Fort Washington Ave, 
New York, NY 

Susheel Kodali is an Interventional Cardiologist and a Cardiologist in New York, New York. Kodali has been practicing medicine for over 25 years and is highly rated in 33 conditions, according to our data. His top areas of expertise are Aortic Valve Stenosis, Tricuspid Regurgitation, Aortic Regurgitation, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR). He is licensed to treat patients in New York. Kodali is currently accepting new patients.

AK
Ajay J. Kirtane
Dr. Ajay J. Kirtane
Interventional Cardiology | Cardiology
Highly rated in
33
conditions
Interventional Cardiology
Cardiology

NewYork-Presbyterian Healthcare System

NewYork-Presbyterian/Columbia University Irving Medical Center

161 Fort Washington Ave, 
New York, NY 

Ajay Kirtane is an Interventional Cardiologist and a Cardiologist in New York, New York. Kirtane has been practicing medicine for over 25 years and is highly rated in 33 conditions, according to our data. His top areas of expertise are Heart Attack, Coronary Heart Disease, Atherosclerosis, Percutaneous Coronary Intervention (PCI), and Atherectomy. He is licensed to treat patients in Massachusetts, California, and New York. Kirtane is currently accepting new patients.

ML
Martin B. Leon
Dr. Martin B. Leon
Interventional Cardiology | Cardiology
Highly rated in
34
conditions
Interventional Cardiology
Cardiology

NewYork-Presbyterian Healthcare System

NewYork-Presbyterian/Columbia University Irving Medical Center

161 Fort Washington Ave, 
New York, NY 

Martin Leon is an Interventional Cardiologist and a Cardiologist in New York, New York. Leon has been practicing medicine for over 48 years and is highly rated in 34 conditions, according to our data. His top areas of expertise are Aortic Valve Stenosis, Tricuspid Regurgitation, Coronary Heart Disease, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR). He is licensed to treat patients in New York. Leon is currently accepting new patients.